News for Infinity Pharmaceuticals, Inc. (INFI)

Renal cancer, also known as kidney cancer, is a disease where malignant (cancer) cells form in the tissues of the kidneys. Smoking, obesity, hypertension,...

Advanced kidney cancer refers to a stage of kidney cancer where the disease has spread beyond the kidney to other parts of the body, requiring more complex...

BOULDER, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- OnKure, Inc. today announced the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer....

Key pancreatic cancer market players include Amgen Inc., Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., NewLink Genetics Corp.,...

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Infinity To Contact Him Directly To Discuss Their Op...

NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity...

File New Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause and Add Advisory Proposal Requesting the Return of Capital to...

LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.20%

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.

NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

/PRNewswire/ -- The hedgehog pathway inhibitors market size is forecasted to increase by USD 385.52 million from 2021 to 2026, at a CAGR of 13%, according to...

Key Companies Covered in the Global Hedgehog Pathway Inhibitors Market Research Report by Research Nester are Mayne Pharma Group Limited, PellePharm, Inc.,...

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on November 17, 2022 Dear Shareholder: We cordially invite you to attend the Annual... | October 5, 2022

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.